000 | 01874 a2200529 4500 | ||
---|---|---|---|
005 | 20250513203405.0 | ||
264 | 0 | _c20000321 | |
008 | 200003s 0 0 eng d | ||
022 | _a0002-9378 | ||
024 | 7 |
_a10.1016/s0002-9378(00)70226-2 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSadovsky, Y | |
245 | 0 | 0 |
_aEffective diminution of amniotic prostaglandin production by selective inhibitors of cyclooxygenase type 2. _h[electronic resource] |
260 |
_bAmerican journal of obstetrics and gynecology _cFeb 2000 |
||
300 |
_a370-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAmnion _xdrug effects |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aChorion _xdrug effects |
650 | 0 | 4 |
_aCyclooxygenase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aDecidua _xdrug effects |
650 | 0 | 4 |
_aDinoprostone _xanalysis |
650 | 0 | 4 | _aElectrophoresis, Polyacrylamide Gel |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Expression Regulation |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunoenzyme Techniques |
650 | 0 | 4 |
_aIndomethacin _xpharmacology |
650 | 0 | 4 |
_aIsoenzymes _xanalysis |
650 | 0 | 4 |
_aLabor, Obstetric _xdrug effects |
650 | 0 | 4 |
_aMyometrium _xdrug effects |
650 | 0 | 4 |
_aNitrobenzenes _xpharmacology |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 |
_aProstaglandin-Endoperoxide Synthases _xanalysis |
650 | 0 | 4 |
_aPyrazoles _xpharmacology |
650 | 0 | 4 |
_aSulfonamides _xpharmacology |
650 | 0 | 4 |
_aTocolytic Agents _xpharmacology |
700 | 1 | _aNelson, D M | |
700 | 1 | _aMuglia, L J | |
700 | 1 | _aGross, G A | |
700 | 1 | _aHarris, K C | |
700 | 1 | _aKoki, A | |
700 | 1 | _aMasferrer, J L | |
700 | 1 | _aOlson, L M | |
773 | 0 |
_tAmerican journal of obstetrics and gynecology _gvol. 182 _gno. 2 _gp. 370-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0002-9378(00)70226-2 _zAvailable from publisher's website |
999 |
_c10648514 _d10648514 |